Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TYMP | P19971 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | XDH | P47989 | 2/20 | 0.41 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.39 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488525 | 1.00 | TDP1 (0.44) | TDP1LMNAHPGDTYMPLGALS8 | |
| SCHEMBL23488175 | 1.00 | TDP1 (0.44) | TDP1LMNAHPGDTYMPLGALS8 | |
| SCHEMBL23488568 | 0.94 | TDP1 (0.47) | TDP1LMNAHPGDTYMPLGALS8 | |
| SCHEMBL23488678 | 0.94 | TDP1 (0.47) | TDP1LMNAHPGDTYMPLGALS8 | |
| SCHEMBL23488695 | 0.90 | TDP1 (0.43) | TDP1TYMPXDHSLC5A2 | |
| SCHEMBL23488435 | 0.90 | TDP1 (0.45) | TDP1TYMPXDHSLC5A2 | |
| SCHEMBL23488686 | 0.89 | TDP1 (0.45) | TDP1LMNAHPGDTYMPLGALS8 | |
| SCHEMBL23488167 | 0.88 | PRKCA (0.45) | TDP1 | |
| SCHEMBL23488632 | 0.87 | TDP1 (0.45) | TDP1XDHSLC5A2 | |
| SCHEMBL23488430 | 0.87 | TDP1 (0.44) | TDP1TYMPXDHSYNJ2SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | TDP1 4093/4885LMNA 4539/4885HPGD 4318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.